Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|July 1, 1993
pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivoJ J Eron, Y K Chow, A M Caliendo, et al.
Clinical Lung Cancer|November 11, 2010
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaborationGabriela A D'Jaen, Liron Pantanowitz, Mark Bower, et al.
Transplantation and Cellular Therapy|September 29, 2022
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge DataTheresa H M Keegan, Ann Brunson, Julianne J P Cooley, et al.
The New England Journal of Medicine|June 5, 1997
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials GroupL D Kaplan, D J Straus, M A Testa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 TeamB J Dezube, J H Von Roenn, J Holden-Wiltse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Highly active antiretroviral therapy and viral response in HIV type 2 infectionChristopher Mullins, Geoffrey Eisen, Stephen Popper, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2024
Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based StudyNaseem S Esteghamat, Ann Brunson, Aaron S Rosenberg, et al.
Future Oncology (London, England)|March 9, 2016
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patientsJoseph M Unger, Dawn L Hershman, Kathryn B Arnold, et al.
Transplantation and Cellular Therapy|November 19, 2023
Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018Bryan Valcarcel, Sara J Schonfeld, Christa L Meyer, et al.
Cancer|September 25, 2014
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective studyJorge J Castillo, Mark Bower, Jérémy Brühlmann, et al.
Pageof 6